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ABSTRACT 
Background: Most ant venoms consist predominantly of small linear peptides, although some 
contain disulfide-linked peptides as minor components. However, in striking contrast to other ant 
species, some Anochetus venoms are composed primarily of disulfide-rich peptides. In this study, we 
investigated the venom of the ant Anochetus emarginatus with the aim of exploring these novel 
disulfide-rich peptides. 
Methods: The venom peptidome was initially investigated using a combination of reversed-phase 
HPLC and mass spectrometry, then the amino acid sequences of the major peptides were determined 
using a combination of Edman degradation and de novo MS/MS sequencing. We focused on one of 
these peptides, U1-PONTX-Ae1a (Ae1a), because of its novel sequence, which we predicted would 
form a novel 3D fold. Ae1a was chemically synthesized using Fmoc chemistry and its 3D structure was 
elucidated using NMR spectroscopy. The peptide was then tested for insecticidal activity and its effect 
on a range of human ion channels. 
Results: Seven peptides named poneritoxins (PONTXs) were isolated and sequenced. The three-
dimensional structure of synthetic Ae1a revealed a novel, compact scaffold in which a C-terminal β-
hairpin is connected to the N-terminal region via two disulfide bonds. Synthetic Ae1a reversibly 
paralyzed blowflies and inhibited human L-type voltage-gated calcium channels (CaV1).  
Conclusions: Poneritoxins from Anochetus emarginatus venom are a novel class of toxins that are 
structurally unique among animal venoms. 
General significance: This study demonstrates that Anochetus ant venoms are a rich source of 
novel ion channel modulating peptides, some of which might be useful leads for the development of 
biopesticides. 
 
 
1. Introduction 
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Venomous animals employ complex biochemical cocktails of small molecules, peptides and 
proteins for the dual purpose of prey capture and defense against predators [1]. Arthropod venoms 
generally comprise a heterogenous mixture of proteins, peptides, salts, biogenic amines and small 
molecules such as alkaloids and acylpolyamines [2]. Significantly, small disulfide-rich peptides are the 
dominant components of most arthropod venoms that have been studied in detail to date, including 
those from spiders [3], scorpions [4] and centipedes [5]. 
The composition of the venom of other invertebrates such as insects, crustaceans and annelid 
worms has been less studied, with some of the first investigations performed only very recently [6-
10]. Surprisingly, despite the ubiquity, abundance and diversity of ants (Hymenoptera: Formicidae), 
with more than 13,000 species described [11], their venoms remain largely unexplored. While some 
hymenopteran subfamilies rely on small-molecule chemical defenses, such as formic acid or alkaloids, 
many others, including wasps, bees, bumblebees and the majority of ant species, have retained the 
ability to sting and those venoms appear to be peptide-rich. Preliminary investigations into the venom 
repertoire of stinging ants demonstrated that peptide-based ant venoms may each comprise up to 
300 peptides [12,13], leading to a conservative estimate of more than 1,500,000 peptides in all ant 
venoms combined. Although such a natural peptide library has immense potential for drug and 
insecticide discovery, very few studies have examined the peptidome of ant venoms. Indeed, to date, 
a total of only 75 peptides have been sequenced from ant venoms [14,15], compared to >1000 for 
spiders, and there have been very few investigations of their three-dimensional structure and 
pharmacological activity [16-18] 
The ant-venom peptides sequenced to date fall into three distinct structural classes: linear (i.e., 
devoid of disulfide bonds); homo- and heterodimers; and inhibitor cystine knot (ICK)-like peptides. 
Our recent mass spectrometry-based survey of 82 stinging ant peptidomes confirmed the prevalence 
of small linear peptides with less than 35 residues and highlighted the presence of disulfide-linked 
peptides in most subfamilies [12]. Interestingly, this study also revealed that several venoms from the 
genus Anochetus (subfamily Ponerinae) have a peculiar composition, consisting almost entirely of 
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monomeric peptides with one or two disulfide bonds [12]. Such disulfide-rich peptides are likely to 
constitute novel families of ant toxins with potentially interesting structural scaffolds and 
pharmacology. We therefore embarked on a study of these disulfide-rich peptidomes, with the goal of 
uncovering new scaffolds and linking them to useful pharmacological properties, in particular against 
ion channels, with a view towards development of insecticides and human therapeutics. 
Anochetus are predatory ant species that subdue small invertebrate prey using their unique 
trapjaws (i.e., forward-facing mandibles that can open to almost 180˚) prior to the injection of venom. 
There have been no studies to date of venom from any Anochetus species, and consequently we 
initiated a detailed investigation of the venom peptidome of A. emarginatus. This led to the isolation 
and characterization of a novel family of neurotoxic disulfide-rich peptides that we named 
poneritoxins (PONTXs). One of these toxins (Ae1a) was shown to be insecticidal and inhibit human 
voltage-gated calcium channels. 
 
 
2. Materials and methods 
2.1.  Ant collection 
Live A. emarginatus workers were collected from both the Nouragues research station (N 
04°05’16’’, W52°40’48’’) and the Kaw area (N 04°32’44’’, W 52°08’03’’) in French Guiana. Voucher 
specimens were deposited in the Laboratório de Mirmecologia collection, Cocoa Research Centre, 
Ilhéus, Bahia, Brazil. Worker ants were stored at –20°C prior to dissection. Ant venom sacs were 
dissected and pooled in 10% v/v acetonitrile (ACN)/water. Samples were centrifuged for 5 min at 
14,400 rpm, then the supernatant was collected and lyophilized prior to storage at –20°C until further 
use. Fifty ant venom sacs dissected from three different colonies collected at the Nouragues station 
were used for investigation of the venom peptidome as well as for the isolation and sequencing of 
poneritoxins. Furthermore, a supplementary venom sample was obtained with 70 venom sacs from a 
single colony, collected at Kaw. This sample was used to check for coelution of native and synthetic 
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poneritoxin on RP-HPLC, and for a preliminary pharmacological screening of the effect of crude 
venom on human ion channels. 
 
2.2. RP-HPLC separation and peptide purification 
A. emarginatus venom was fractionated by semi-micro RP-HPLC using an Xterra-C18 column 
(5 µm, 2.1 x 100 mm; Waters, USA) with a gradient comprised of solvent A (0.1% v/v trifluoroacetic 
acid (TFA)) and solvent B (acetonitrile (ACN)/0.1% v/v TFA). The percentage of solvent B was modified 
as follows: 0% for 5 min, 0–60% over 60 min, and 60–90% over 10 min at a flow rate of 0.3 ml.min–1. 
The eluate was monitored by UV absorbance at 215 nm using a diode-array detector. All analyses 
were performed on an Agilent HP 1100 system (Agilent, USA). Peptide elution was monitored in real 
time and fractions were collected manually for each eluting peak. Each fraction was then dried and 
reconstituted in 50 µL of 0.1% v/v TFA/water for offline matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) analysis. Further peptide purification was achieved 
by subjecting C18 fractions to a second reversed-phase chromatography step on a Jupiter C4 column 
(5µm, 4.6 x 250 mm; Phenomenex, USA). 
 
2.3. Mass spectrometry analysis 
MS analyses were performed on a Voyager DE-Pro MALDI-TOF mass spectrometer (Applied 
Biosystems, CA, USA). Samples were prepared as previously reported [19] using ferulic acid (FA) 
matrix dissolved in 20% ACN/0.1% v/v TFA/water at a concentration of 10mg/mL with 100 mM serine 
as an additive. The FA/serine combination was shown to be the most efficient matrix for analysis of 
crude ponerine ant venoms via MALDI-TOF MS [19]. 0.5 µL of each sample was deposited on the 
MALDI target plate followed by 0.5 µL of the FA matrix. Each mass spectrum was externally calibrated 
using a mixture of peptides of known molecular mass in the same m/z range (Peptide Calibration Mix 
4, LaserBio Labs, Sophia-Antipolis, France). Lastly, 0.5 µL of the calibration mixture was co-crystallized 
with 0.5 µL of the matrix and placed adjacent to each sample and analyzed separately. All calibration 
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spectra were acquired in automated mode to maximize mass accuracy and reproducibility. All spectra 
were acquired in reflector mode and sample spectra were calibrated automatically using the 
sequence module of the Voyager® Control Software (Applied Biosystems, CA, USA). Five spectra of 50 
laser shots per spectrum were accumulated for each sample based on defined acceptance parameters 
and adequate signal intensity in the 500–10,000 m/z range. Mass spectra were collected in positive 
ion mode with 20 kV acceleration. Signals below 500 m/z were not recorded as they were comprised 
of mostly matrix-related ion clusters. 
 
2.4.  Mass spectra analysis 
All mass spectra were processed with Data Explorer® 4.11 software (Applied Biosystems, CA, 
USA) and subjected to baseline correction with a correlation factor of 0.7 and Gaussian smoothing to 
reduce noise with a 5-point filter width. Supplementary masses resulting from sodium (+22 Da) and 
potassium (+38 Da) adducts were manually removed from all mass lists. Masses matching within 
± 1.0 Da in neighboring HPLC fractions were considered to be identical peptides from incomplete 
separation. Two-dimensional scatter plots, also known as "2D venom landscapes" [20], were 
constructed using SigmaPlot 12.0 software (Systat, CA, USA). All peptide masses detected in each 
HPLC fraction were plotted as a function of their m/z values (y-axis) and their HPLC retention time (x-
axis), the latter being a reflection of their hydrophobicity. 
The number of residues per peptide was estimated using the theoretical average amino acid 
molecular weight (111.1254 Da) determined using the statistical occurrence of amino acids in 
proteins, calculated with the formula C4.9384H7.7583N1.3577S0.0417. 
 
2.5. Disulfide bond reduction and alkylation 
The presence of disulfide-linked peptides in ant venoms was determined via chemical reduction 
of crude venoms and subsequent analysis of HPLC fractions. Disulfide reduction was achieved by 
mixing 5 µL of crude venom or HPLC fraction was incubated with 10 µL of 100mM ammonium 
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bicarbonate buffer (pH 8) containing 6 M guanidine and 10 mM dithiothreitol (DTT) for 30 min at 
56°C. Prior to MS analysis, reduced venoms or fractions were desalted using ZipTip® C18 pipette tips 
(Millipore, Billerica, MA, USA). As chemical reduction results in a mass increase of 2 Da for each 
disulfide bond, the examination of mass shifts in the mass spectra of native and reduced samples 
permitted the number of disulfide bonds in the corresponding peptides to be determined. The 
disulfide-linked peptides were purified and further analyzed after reduction/alkylation to confirm 
their disulfide-bond content: following reduction with DTT, the peptides were alkylated by incubation 
in 50 mM iodoacetic acid (IAA) for 15 min at room temperature in the dark. 
 
2.6. Chemistry-based sequencing 
Purified peptides were subjected to Edman degradation on an gas-phase sequencer model ABI 
492 (Applied Biosystems, CA, USA). The phenylthiohydantoin (PTH) amino acid derivatives generated 
at each sequence cycle were identified and quantified on-line with an Applied Biosystems Model 140C 
HPLC system using the Applied Biosystems Model 610A data analysis system for protein sequencing. 
The PTH-amino acid standard kit was used and reconstituted according to the manufacturer’s 
instructions. The procedures and reagents were used as recommended by the manufacturer.  
 
2.7. De novo MS-based peptide sequencing 
After reduction and alkylation, an aliquot (1/3) of each of the six purified peptides (i.e. PONTX-
Ae1b; Ae1c; Ae1d; Ae1e; Ae1f and Ae1g) was subjected to de novo sequencing using an AB Sciex 5600 
TripleTOF 5600 System coupled to a Shimadzu 30 series HPLC system (ABSciex, Concord ON, Canada). 
LC separation was achieved using a C18 column (2.1 x 100 mm, 1.8 µm, 300 Å; Agilent, Santa Clara CA, 
USA) with a fast gradient of 2–50% solvent B (90% ACN/0.1% formic acid) using a flow rate of 0.15 
ml.min–1 over 4 min. One full scan cycle of the mass range (300–1800 m/z) followed by multiple 
tandem mass cycles (MS/MS) (80–1400 m/z) was applied using a rolling collision energy relative to the 
m/z and charge state of the precursor ion up to a maximum of 80 eV. The full-scan MS had a duration 
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of 14 min with a cycle time of 1.15 s (total of 729 cycles). The maximum number of candidate ions 
monitored per cycle was 20 and the ion tolerance was 0.1 Da. External calibration was applied before 
acquisition. All data processing was conducted using Analyst 1.6 software and individual ion spectra 
were manually interpreted.  
 
2.8. Chemical synthesis 
Protected Fmoc-amino acid derivatives were purchased from Novabiochem or Auspep 
(Melbourne, Australia). The following side chain protected amino acids were used: Cys(Trt), His(Trt), 
Hyp(tBu), Tyr(tBu), Lys(Boc), Trp(Boc), Arg(Pbf), Asn(Trt), Asp(OtBu), Glu(OtBu), Gln(Trt), Ser(tBu), 
Thr(tBu), Tyr(tBu). All other Fmoc amino acids were unprotected. Dimethylformamide (DMF), 
dichloromethane (DCM), diisopropylethylamine (DIEA), and (TFA) were supplied by Auspep as 
peptide-synthesis grade. 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HBTU), triisopropylsilane (TIPS), HPLC-grade acetonitrile, aceticanhydride and methanol were 
supplied by Sigma Aldrich (Sydney, Australia). Ethanedithiol (EDT) was supplied by Merck (Sydney, 
Australia). 
C-terminal amide and C-terminal carboxyl versions of the ant venom peptide Ae1a were 
synthesized on a Symphony automated peptide synthesizer (Protein Technology, Tucson AZ, USA) 
using Rink amide resin (0.1 mmol) and Fmoc-Cys-Wang resin (SV =0.5mmol/g), respectively. Peptides 
were assembled using HBTU/DIEA in situ activation protocols [21] to couple the Fmoc-protected 
amino acid to the resin (5 equiv. excess; coupling time 5 min). Fmoc deprotection was performed with 
30% piperidine/DMF for 1 min followed by a 2-min repeat. Washes were performed 10 times after 
each coupling as well as after each deprotection step. After chain assembly and final Fmoc 
deprotection, the peptide resins were washed with methanol and dichloromethane and dried in a 
stream of nitrogen. Cleavage of the peptide resin was performed at room temperature in 
TFA/H2O/TIPS/EDT (87.5/5/5/2.5) for 3 h. Cold diethyl ether (30 ml) was then added to the filtered 
cleavage mixture and the peptide precipitated. The precipitate was collected by centrifugation and 
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subsequently washed with further cold diethyl ether to remove scavengers. The final product was 
dissolved in 50% aqueous ACN/0.1% TFA and lyophilized to yield a solid white product. The crude, 
reduced peptide was analyzed using RP-HPLC to determine purity, and the correct molecular weight 
was confirmed using electrospray ionisation (ESI) MS. 
Purified, reduced amidated and carboxyl forms of Ae1a (1 mg/ml) were oxidized by stirring at 
room temperature in 10% dimethyl sulfoxide (DMSO)/0.1 M NH4HCO3 pH 8.0, for 16 h. The solutions 
were subsequently diluted to a DMSO concentration < 5 % prior to RP-HPLC purification. A single main 
oxidized product was purified to >95% purity and lyophilized. 
Analytical HPLC runs were performed using a Shimadzu HPLC system LC10A (Shimadzu, Kyoto, 
Japan) with dual wavelength detection at 214 nm and 254 nm. A reversed-phase C18 column (Zorbax 
300-SB C18; 4.6 x 50 mm, Agilent) was used with a flow rate of 2 ml
.min-1. Gradient elution was 
performed with the following buffer systems: A, 0.05% TFA in water and B, 0.043% TFA in 90% ACN in 
water, from 0% to 80% B in 20 min. The crude peptides and oxidized peptides were purified by semi-
preparative HPLC on a Shimadzu HPLC system LC8A using a 25 cm x 10 mm reversed-phase C18 column 
(Grace, Columbia MD, USA) running at a flow rate of 5 ml.min–1 with a 1%/min gradient of 5–50% B. 
The purity of the final product was evaluated by analytical HPLC (Zorbax 300SB C18, 4.6 x 100 mm, 
Agilent) using a flow rate of 1 ml.min–1 and a 1.67%/min gradient of 5–45% B. The purity of all 
synthetic peptides was > 95%. 
Peptide concentrations used during in vitro screening were calculated based on peak size 
detected at 214 nm relative to that of a peptide standard of known concentration established via 
amino acid analysis. Molecular extinction coefficients were calculated for the standard and the 
peptide of interest by applying increments established by Buck et al. [22]. 
ESI mass spectra were collected in-line during analytical HPLC runs on an Applied Biosystems API-
150 spectrometer operating in positive ion mode with an OR of 20, Rng of 220 and a Turbo spray of 
350 degrees. Masses between 300 and 2200 amu were detected (step 0.2 amu, dwell 0.3 ms). 
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2.9. Peptide structure determination 
Two-dimensional homonuclear NMR spectroscopy was used to determine the structure of Ae1a. 
Lyophilized Ae1a was resuspended at a final concentration of 2 mM in 300 µl of 20 mM sodium 
phosphate, pH6 containing 5% D2O. An additional sample was prepared by lyophilizing the above 
sample and resuspending it in 100% D2O. Spectra were acquired at 25˚C on a Bruker AVANCE 600 MHz 
spectrometer equipped with a cryoprobe (Bruker, Billerica MA, USA). Resonance assignments were 
obtained using a combination of 2D 1H-15NHSQC, 1H-13CHSQC (in 100% D2O) and TOCSY spectra. 
Interproton distance restraints were obtained from a 2D NOESY spectrum acquired with a mixing time 
of 300 ms. Spectra were processed using Topspin (Version 3.2, Bruker) and analyzed using CcpNmr 
Analysis 2.4.1 [23]. Chemical shift assignments have been deposited in BioMagResBank (accession 
number 25971). Dihedral-angle restraints were derived from TALOS+ chemical shift analysis [24] and 
the restraint range was set to twice the estimated standard deviation. The NOESY spectrum was 
manually peak picked, then the torsion angle dynamics package CYANA 3 [25] was used to 
automatically assign the peak list, extract distance restraints, and calculate an ensemble of structures. 
During the process of automatic NOESY spectrum assignment, CYANA assigned 95.8% of all NOESY 
cross-peaks. The final structure was calculated using a total of 190 interproton distance restraints, 6 
disulfide-bond distance restraints, and 27 dihedral-angle restraints; 200 structures were calculated 
and the top 20 were selected on the basis of final CYANA penalty function values and stereochemical 
quality as judged by MolProbity [26]. Atomic coordinates for the final ensemble of 20 structures are 
available from the Protein Data Bank (PDB ID 2NBC). 
 
2.10. Insecticidal bioassay 
Synthetic Ae1a was dissolved in insectsaline [27] and injected into the ventro-lateral thoracic 
region of sheep blowflies (Lucilia cuprina, mass 28.5–30.7 mg), using a 1.0 ml disposable syringe (B-D 
Ultra Fine, Terumo Medical Corporation, Tokyo, Japan) and a fixed 29 gauge needle fitted to an 
Arnold manual micro-applicator (Burkard Manufacturing Co-Ltd., Uxbridge, UK). A maximum volume 
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of 2 µl was injected per fly. Thereafter, the flies were individually housed in 2-ml tubes and paralytic 
activity was determined after 1 h and 24 h. A total of three tests was carried out and, for each test, 
seven doses of Ae1a (n=10 flies per dose) and the appropriate control (insect saline; n= 20 flies each) 
were used. PD50 values were calculated as described previously [28,29]. 
 
2.11. Ion channel assays 
The effect of Ae1a on a range of voltage- and ligand-gated ion channels was determined by 
measuring Ca2+ responses using a fluorescent imaging plate reader (FLIPRTETRA) and cells loaded with 
Calcium 4 dye (Molecular Devices, Sunnyvale CA, USA). The SH-SY5Y neuroblastoma cell line was used 
as previously described for assaying the voltage-gated ion channels CaV1, CaV2, NaV1.7 and the ligand-
gated α7 nicotinic acetylcholine receptor (nAChR) [30,31]. SH-SY5Y cells were plated at 40,000 cells 
per well on a 384-well flat clear bottom black plate (Corning, NY, USA) and cultured at 37°C in a 
humidified 5% CO2 incubator for 48 h before assay. The medium was removed and the cells loaded 
with 20 μl per well of Calcium 4 dye reconstituted in an assay buffer containing (in mM) 140 NaCl, 
11.5 glucose, 5.9 KCl, 1.4 MgCl2, 1.2 NaH2PO4, 5 NaHCO3, 1.8 CaCl2 and 10 HEPES pH 7.4. Cells were 
then incubated for 30 min at 37°C in a humidified 5% CO2 incubator. For the CaV1 assay, 1 μM -
conotoxin CVID (a CaV2 blocker) was added to the dye; for the CaV2 assay,10 μM nifedipine (a CaV1 
blocker) was added to the dye; and for the α7 nAChR assay, 10 μM PNU-120596 (an α7 agonist) was 
added to the dye. 
Ca2+ fluorescence responses were recorded using excitation and emission wavelengths of 470–
495 nm and 515–575 nm, respectively. Responses were recorded for 10 s to set the baseline, 600 s 
after the addition of either A. emarginatus crude venom (10, 1 and 0.1μg/well) or various 
concentrations of Ae1a, and for a further 300 s after the addition of various activators (90 mM CaCl2 
for the CaV1 and CaV2 assays, 30 μM choline for the α7 nAChR assay, or 30 μM veratridine for the 
NaV1.7 assay). Maximum fluorescent responses were corrected against baseline and used to plot the 
intracellular calcium influx. Curve fitting (nonlinear regression with log[inhibitor] versus normalized 
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response and variable Hill slope) was performed using GraphPad Prism Version 6 (GraphPad Software, 
San Diego CA, USA). 
 
3. RESULTS 
3.1. 2D landscape of A. emarginatus venom 
A previous investigation of Anochetus spp. crude venoms revealed the presence of numerous 
peptides cross-linked by one or two disulfide bonds [12]. Our analysis of A. emarginatus venom using 
RP-HPLC coupled to off-line MALDI-TOF MS further highlighted the unusual nature of the venom 
peptidome compared to previously described ant toxins [14]. First, our LC-MS analysis revealed only 
35 masses in the venom (Table 1); second, the peptides were relatively small (1460–2100 Da, which 
corresponds to peptides containing 13–19 residues) (Fig. 1) and relatively hydrophilic, eluting 
between 10% and 25% ACN (retention time 15–30 min, Fig. 2A); third, after chemical reduction of 
each HPLC fraction, a mass shift of +4 Da occurred for almost all of the masses detected, indicating 
that A. emarginatus venom is composed almost entirely of peptides with two disulfide bonds. In 
contrast, we detected only one linear peptide (m/z 1623.58) in A. emarginatus venom. 
 
3.2. Poneritoxin sequences 
All ants (>13,000 extant species) are grouped into a single family and consequently we propose 
to slightly modify the standard nomenclature proposed for naming venom peptides from spiders [32], 
centipedes [5], and sea anemones [33] and to use the 16 extant subfamilies to classify ant venom 
peptides. Thus, we use the term "poneritoxin" (abbreviated PONTX) to denote venom peptides from 
Anochetus and other species in the ant subfamily Ponerinae [15]. We purified the seven most 
abundant disulfide-linked poneritoxins (i.e., PONTX-Ae1a; Ae1b; Ae1c; Ae1d; Ae1e; Ae1f; Ae1g) using 
a combination of C18 and C4 RP-HPLC. These poneritoxins are the first venom peptides to be isolated 
from Anochetus venom.  
N-terminal sequencing of Ae1a using Edman degradation yielded the 16-residue sequence 
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WCASGCRKKRHGGCSC, with a calculated mass of 1732.73 Da. Thus, the measured m/z value of 
1733.64 [M+H]+ for the native peptide is consistent with C-terminal amidation, for which the 
predicted mass would be 1732.72 Da (Fig. 2). The six remaining purified peptides were subjected to de 
novo MS-based sequencing using a high-resolution AB Sciex Triple TOF 5600 mass spectrometer. Each 
peptide was individually selected for MS/MS analysis and fragmented by collision-induced 
dissociation. Sufficient fragmentation and good sequence coverage were obtained for each of the 
peptides and allowed almost complete sequence characterization. Full sequences were finalized by 
combining the MS and MS/MS data within information from Edman degradation. Similar to Ae1a, the 
other six poneritoxins are also C-terminally amidated and are slightly larger than Ae1a, comprising 
either18 residues (PONTX-Ae1b, PONTX-Ae1c, PONTX-Ae1d, PONTX-Ae1e and PONTX-Ae1g) or 19 
residues (PONTX-Ae1f). They show 40–90% sequence identity with Ae1a. Ae1a, PONTX-Ae1b, PONTX-
Ae1c and PONTX-Ae1d are 61–94% identical and are very basic (predicted pI of 9–9.3). PONTX-Ae1g 
and PONTX-Ae1e are more dissimilar (41–50% identity with Ae1a) and less basic (predicted pI of 8.5–
8.6). PONTX-Ae1f is the most hydrophobic of the seven peptides and the least basic (pI~7.5). 
An alignment of the sequences of the seven peptides (Table 2) reveals several strictly conserved 
features, including the four cysteine residues, a glycine immediately preceding the second cysteine, 
and a doublet of glycine residues preceding the third cysteine residue. The glycine content is 
unusually high in these peptides, ranging from 16.7% in PONTX-Ae1c and PONTX-Ae1d to 33.3% in 
Ae1e. These peptides are clearly paralogs, and therefore should be classified in the same isotoxin 
group, but they have no sequence similar similarities to any previously described venom peptides. The 
unique amino acid sequence and cysteine framework of the poneritoxins indicate that they might 
have a unique 3D fold, and hence we decided to pursue structural characterization of Ae1a. 
 
3.3.  Synthesis and NMR structure of PONTX-Ae1a 
Synthetic Ae1a was produced by solid-phase peptide synthesis. Oxidation of the synthetic linear 
peptide resulted in one major peak that coeluted with the native peptide on RP-HPLC, consistent with 
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formation of the correct disulfide-bind isomer. The three-dimensional structure of synthetic Ae1a was 
elucidated using homonuclear NMR methods. Fig. 3B shows a stereoview the ensemble of 20 
conformers representing the solution structure of PONTX-Ae1a. The disulfide connectivity for PONTX-
Ae1a was determined by performing three separate structure calculations with the three possible 
disulfide isomers (i.e., Cys2–Cys14/Cys6–Cys16; Cys2–Cys6/Cys14–Cys16; and Cys2–Cys16/Cys6–Cys14). Only 
the Cys2–Cys14/Cys6–Cys16 connectivity was consistent with the pattern of NOEs seen in the NOESY 
spectrum and this connectivity was the only one to yield no restraint violations in the structure 
calculations. We therefore infer this to be the native disulfide connectivity for Ae1a. 
The structural statistics for the ensemble of PONTX-Ae1a structures are summarized in Table 3. 
The structure is highly precise, with a backbone rmsd of 0.17 ± 0.04 Å over residues 2–16. The 
stereochemical quality of the structure is also very high, with MobProbity analysis revealing a 
complete absence of steric clashes and 93.6% of residues in the most favored region of the 
Ramachandran plot. The structure ranks as high-resolution based on these measures of precision and 
stereochemical quality [34]. 
Ae1a forms a compact structure in which a C-terminal -hairpin is connected to the N-terminal 
region via the two disulfide bonds. This two-disulfide structure appears to be a novel fold that has not 
been previously reported for any other toxin. A DALI comparison with the PDB was not possible 
because of the small size of the toxin (the cut-off size for DALI analysis is 20 residues). Mapping the 
electrostatic potential onto the surface of Ae1a (Figure 3C) revealed that the C-terminal -hairpin is 
highly cationic, with two positively charged residues emanating from -strand 1 (Arg7/Lys8) and three 
from the -hairpin loop (Lys9/Arg10/His11). It remains to be determined whether this is linked to the 
inherent biological activity of the toxin. 
 
3.4. Insecticidal activity 
Injection of synthetic Ae1a into sheep blowflies (Lucilia cuprina) resulted in paralysis; the PD50 
measured 1h after injection was 8.9 ± 3.1 nmol/g (Fig. 4).The activity of the toxin was completely 
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reversible and all of the flies recovered within 24h following injection. No lethal effects of Ae1a were 
observed within the dose range tested. 
 
3.5. Effects on human ion channels 
Crude venom from A. emarginatus was screened in a FLIPR-based assay to examine potential 
activity against human voltage-gated calcium (CaV) and sodium (NaV) channels as well the ligand-gated 
α7 nAChR endogenously expressed in SH-SY5Y cells. These pharmacological targets are of particular 
interest for the development of therapeutic agents and are currently part of intense screening 
programs to find selective agonists and antagonists. No activity was observed against NaV1.7, CaV2 
channels, or the α7 nAChR (data not shown) but the crude venom inhibited calcium entry via CaV1 
channels (Fig.5A). Moreover, synthetic Ae1a completely abolished the CaV1 response in SH-SY5Y cells 
with an IC50 of 4.6 μM (Fig.5B). Interestingly, the activity of Ae1a against CaV1 channels was 
completely dependent on C-terminal amidation (Fig. 5C), indicating that the C-terminus of Ae1a plays 
a crucial role in its interaction with this ion channel. 
 
4. DISCUSSION 
Ant venom represents an untapped resource for the discovery of peptides with novel 
pharmacology and structure. 3D structures have been reported for only two ant-venom peptides, 
namely the heterodimeric, three-disulfide ectatomin from Ectatomma tuberculatum [46] and 
poneratoxin, a 25-residue linear peptide from Paraponera clavata [47]. A previous study highlighted 
that several ant venoms from the genus Anochetus were almost entirely composed of small peptides 
with one or two disulfide bonds [12]. Since two-disulfide peptides have been seldom described, we 
deemed the potential for discovery of a novel toxin scaffold from the venom of Anochetus 
emarginatus to be very high. 
Determination of the structure of one of the poneritoxins from A. emarginatus, Ae1a, revealed a 
unique β-hairpin fold stabilized by two disulfide bonds. Animal venom peptides are often structured 
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by multiple disulfide bonds and therefore exhibit a wide variety of folds. Except for cone snail venoms 
(e.g., α-conotoxins; [35]), small venom peptides (<30 aa) structured by two disulfide bonds are rare in 
other venomous animals, although they have been occasionally noted in venoms from 
hymenopterans (e.g., apamin, tertiapin, MCDP [36-38]), and snakes (e.g., sarafotoxins [39]).There is 
no significant sequence or structural homology between these toxins and the poneritoxins described 
in the current study (Table 4). Figure 6 shows that, in striking contrast with Ae1a, the secondary 
structures of most small two disulfide-bonded peptides are dominated by α-helices (e.g., tertiapin, 
sarafotoxin, and α- and ρ-conotoxins) [40-43]. However, despite very distinctive amino acid 
sequences, the secondary and tertiary structures of Ae1a and χ-conotoxin MrIA are quite similar 
(compare Fig. 6a and 6b). χ-Conotoxin MrIA is a 13-residue peptide isolated from the venom of Conus 
marmoreus that inhibits the norepinephrine transporter [41]. Both toxins have a β-hairpin motif with 
two antiparallel strands connected by a turn. Nevertheless, the cysteine frameworks of Ae1a and χ-
conotoxin MrIA (C-C-C-C and CC-C-C, respectively) and their disulfide connectivities (C1-C3, C2-C4 and 
C1-C4, C2-C3, respectively) are quite different. Thus, we conclude that 3D structure of Ae1a is distinctly 
different from other venom peptides, including all known CaV channel toxins, thus providing a new 
scaffold for drug design and protein engineering applications. 
Ae1a is a moderately potent insecticidal peptide toxin, having a PD50 that is about 40-fold higher 
than the LD50 reported for the most potent insecticidal spider venom peptides that we have tested 
using the same assay [44,45]. Nevertheless, the ability of Ae1a to induce fast and completely 
reversible paralysis in insects could make it an interesting lead molecule for the development of 
bioinsecticides that aim to minimize effects on beneficial insect species. While spraying such a 
reversible bioinsecticide on a broad-acre crop would initially paralyse all targeted insect species, most 
of them would recover and only pest insects that continued to consume the crop would get entangled 
in a cycle of paralysis-recovery-consumption-paralysis. This would make these insects easy prey for 
predatory arthropod species and also inhibit their growth, ultimately leading to death. Reversibly 
paralytic insecticides would also be ideal for expression in transgenic plants [46], targeting only those 
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pests that continuously consume them. 
Ion channels are the most common molecular target of disulfide-rich neurotoxic peptides from 
arthropod venoms [47,48]. CaV channels in particular are targeted by many venom peptides with 
diverse selectivity for both vertebrate and invertebrates [49-51]. Here, we demonstrated that Ae1a 
blocks vertebrate L-type CaV channels (CaV1), albeit with low potency (IC50 ~4.6 M). Interestingly, 
very few venom peptides have been characterized that modulate the activity of vertebrate L-type 
calcium channels. Calciseptine and calcicludine, isolated from the venoms of the black mamba 
(Dendroaspis polylepsis) and green mamba (D.angusticeps) respectively, block vertebrate CaV1 
channels [51,52]. Peptide toxins CSTX-1 and ω-TRTX-Cc1a isolated from venoms of the spiders 
Cupiennius salei and Pelinobius muticus respectively, are selective inhibitors of Cav1 channels [53,54]. 
Among ants, the heterodimeric peptide Et-1 from Ectatomma tuberculatum venom is capable of 
inhibiting whole-cell L-type calcium currents in isolated rat ventricular myocytes [17]. These other 
toxins that modulate that activity of CaV1 channels have no significant sequence or structural 
homology with Ae1a. 
In this study, we cannot assume that Ae1a also targets insect CaV channels because it has low 
potency against vertebrate Cav1 channels. Considering that the level of identity between insect CaV 
channels and their closest human ortholog is only ~66% [55], this paucity of venom peptides with 
activity against vertebrate CaV channels is perhaps not surprising. Ae1a could possibly have more 
profound effects on insect CaV channels or other types of insect ion channels. More extended 
pharmacological studies using insect neurons are therefore required to determine the ecologically 
relevant molecular target of Ae1a in insects. Following the rational nomenclature rules for venom 
peptides, this toxin should be named U1-PONTX-Ae1a, since the prefix “U” indicates that the 
pharmacological target is not known [32]. 
From an evolutionary perspective, the venom peptidome presented in this study is intriguing. 
Our data reveal that A. emarginatus venom, and potentially venom from other Anochetus species, 
have unique features compared to the venom from other stinging ants [14]. First, the venom is 
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unusual for ants in being composed almost entirely of disulfide-linked peptides. Second, 
A. emarginatus venom is simpler than other ant venoms as it contains only 35 peptides, whereas 
more than 300 peptides were found in venom from the related ponerine species Dinoponera 
quadriceps [13]. Third, almost all of the poneritoxins found in A. emarginatus venom contain two 
disulfide bonds and are similar in size (13–19 residues), suggestive of divergent evolution from a 
single ancestral gene. 
None of the poneritoxins characterized here have homology to known venom peptides from ants 
or other venomous animals. The seven poneritoxins are paralogs, containing a conserved disulfide 
scaffold (CX3CX6-8CX1C) with either minor differences in their amino acid sequence (e.g., PONTX-Ae1c 
and PONTX-Ae1d differ by only one residue), or quite divergent primary structures (e.g., PONTX-Ae1f). 
Presumably, this divergence of sequence suggests a range of potency, selectivity, and/or diverse 
modes of action among these toxins as is often observed in other arthropod venoms in which 
subclasses of toxins from a single venom simultaneously target various pharmacological classes of 
receptors to enhance venom efficacy. As the number of peptides detected in A. emarginatus venom is 
comparatively small, it would nevertheless be expected that structural divergence originating from a 
very limited set of genes could allow for the diversification of the pharmacological activities and 
efficacy of the venom. 
Based on examination of the 2D venom landscapes of both Anochetus and Odontomachus, the 
venom composition and structural diversity appear to be quite dissimilar [56,57]. These closely 
related ant genera share morphological and behavioral features: they both use their trapjaws to 
capture prey, followed by a paralyzing sting. However, the poneritoxins described here from 
A. emarginatus diverge significantly from the venom peptides found in six species of the sister genus 
Odontomachus which are dominated by linear peptides with only a minor proportion of toxins 
containing one disulfide bond [12,19]. This suggests rapid diversification of their venoms since these 
genera separated ~30 Mya, presumably in response to ecological cues [58]. It will be interesting in the 
future studies to compare the venom peptidome of A. emarginatus with that of Anochetus and 
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Odontomachus species that inhabit vastly different ecological niches, such as ground-dwelling species 
and species that have very different diets. 
 
5. Conclusions 
In summary, our data suggest that Anochetus have evolved a novel molecular strategy for the 
chemical immobilization of prey. The unique β-hairpin fold found in Anochetus poneritoxins has 
presumably contributed to the evolutionary success of this genus, which is abundant and widespread 
in tropical and subtropical regions of the world. Exploration of the 34 other poneritoxins reported 
here, as well as novel poneritoxins found in venom from the 114 currently described Anochetus 
species [11], will undoubtedly lead to the discovery of novel ion channel ligands as well as lead 
molecules for the discovery of novel drugs and bioinsecticides. 
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FOOTNOTES 
The protein sequence data reported in this paper will appear in the UniProt Knowledgebase under 
the accession numbers C0HJY4; U1-Poneritoxin-Ae1a (U1-PONTX-Ae1a), C0HJY5; U1-Poneritoxin-Ae1b 
(U1-PONTX-Ae1b), C0HJY6; U1-Poneritoxin-Ae1c (U1-PONTX-Ae1c), C0HJY7; U1-Poneritoxin-Ae1d (U1-
PONTX-Ae1d), C0HJY8; U1-Poneritoxin-Ae1e (U1-PONTX-Ae1e) C0HJY9; U1-Poneritoxin-Ae1f (U1-
PONTX-Ae1f), C0HJZ0; U1-Poneritoxin-Ae1g (U1-PONTX-Ae1g). 
The abbreviations used are: RP-HPLC, reverse phase-high performance liquid chromatography; LC, 
liquid chromatography; MS, mass spectrometry; ACN, acetonitrile; TFA, trifluoroacetic acid; MALDI, 
matrix-assisted laser desorption/ionization; TOF, time-of-flight; FA, ferulic acid; DTT, dithiothreitol; 
PTH, phenylthiohydantoin; DMF, dimethylformamide; DCM, dichloromethane; DIEA, 
diisopropylethylamine; HBTU, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate; TIPS, triisopropylsilane; EDT, ethanedithiol, ESI, electrospray ionization; DMSO, 
dimethyl sulfoxide; nAChR, acethylcholine receptor; NMR, nuclear magnetic resonance. 
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FIGURE 1. Venom peptidome of Anochetus emarginatus. 2D landscape representation of 
the venom profile of A. emarginatus. Peptide masses from LC-MS analysis are shown on the 
ordinate axis, while RP-HPLC retention time (a measure of peptide hydrophobicity) is shown 
on the abscissa. The venom is dominated by peptides with two disulfide bonds (grey 
circles).The black circle indicates the only peptide that was found to lack disulfide bonds. 
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FIGURE 2. Isolation of Ae1a. (A) RP-HPLC chromatogram resulting from fractionation of crude 
venom from Anochetus emarginatus on a C18 column. Peaks containing the seven peptides that 
were selected for purification are labeled. (B) Chromatogram showing purification of peptide 
Ae1a using C4 RP-HPLC. (C) MALDI-TOF MS spectrum of purified native Ae1a. (D) Amino acid 
sequence of PONTX-Ae1a determined using Edman degradation and mass spectrometry. 
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FIGURE3. Solution structure of Ae1a (PDB: 2NBC). (A) Primary structure of Ae1a. The 
secondary structure of Ae1a determined from the NMR-derived solution structure is shown 
above the sequence, with β-strands denoted by cyan arrows. Disulfide bonds are highlighted in 
red. (B) Stereoview of the ensemble of 20 structures of Ae1a overlaid for best fit over the 
backbone atoms of residues 2–16. β-Strands are colored cyan and the two disulfide bonds are 
shown as red tubes. (C) Electrostatic surface of Ae1a. Positively- and negatively-charged 
regions are shown in blue and red, respectively. The side chains are displayed for residues that 
contribute to the positively-charged surface. 
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FIGURE 4. Insecticidal potency of Ae1a. Dose-response curve resulting from injection of Ae1a 
into sheep blowflies (Lucilia cuprina). Data points are mean ± SEM. The percentage of 
paralyzed blowflies was determined after 1 h, and the median paralytic dose (PD50) was 
determined from the average ± SEM of three independent experiments. 
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FIGURE 5. Activity of Anochetus emarginatus venom and Ae1a peptide against channels 
endogenously expressed in SH-SY5Y cells. (A) Crude venom was reconstituted in assay buffer 
and applied at 10, 1 and 0.1 μg/well to SH-SY5Y cells loaded with Calcium 4 dye in the presence 
of 1 mΜ -conotoxin CVID (CaV2 blocker). After 10 min incubation with the venom, cells were 
activated with 90 mM KCl and 5 nM CaCl2 and the intracellular calcium responses recorded. 
A. emarginatus venom reduced the CaV1 response to 60% and 40% at concentrations of 10 and 
1 μg/well, respectively, but was inactive at a dose of 0.1 μg/well. (B) Dose-response curves for 
the modulation of CaV1 and CaV2 responses in SH-SY5Y cells by Ae1a. Synthetic Ae1a inhibited 
the CaV1 response with an IC50 of 4.6 μM, but had no effect on CaV2. (C) At a concentration of 
30 µM the non-amidated form of Ae1a caused no inhibition of CaV1 responses in SH-SY5Y cells. 
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FIGURE 6. Comparison of the structure of Ae1a with other small two-disulfide venom peptides. (A-F) 
Ribbon representations of the 3D structures of (A) Ae1a (PDB 2NBC); (B) χ-Conotoxin MrIA (PDB 
2EW4); (C) ρ-Conotoxin TIA (PDB 2LR9); (D) α-Conotoxin MII (PDB 1M2C); (E) Tertiapin (PDB 1TER); 
(F) Sarafotoxin 6b (PDB 1SRB). Disulfide bonds are indicated by yellow sticks and spheres, while β-
strands and α-helices are highlighted by respectively by cyan arrows and orange helices. 
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Table 1 
Mass fingerprint of Anochetus emarginatus venom. Masses in bold indicate the seven 
poneritoxins that were purified and sequenced in this study. The shaded mass indicates a 
linear peptide; all other peptides are crosslinked by two disulfide bonds. 
 
Fraction RT (min) m/z [M+H+] 
Ƒ 1 15.3 1790.64 
Ƒ 2 16.2 1689.58 
Ƒ 3 16.7 1745.85 
Ƒ 4 17.2 1727.80 
Ƒ 4 17.2 1850.90 
Ƒ 5 18.0 1733.64 
Ƒ 6 19.2 1916.96 
Ƒ 7 20.0 1770.80 
Ƒ 7 20.0 1926.90 
Ƒ 8 20.8 1975.12 
Ƒ 9 21.3 1689.80 
Ƒ 9 21.3 1828.90 
Ƒ 10 21.6 1901.05 
Ƒ 11 22.1 1713.80 
Ƒ 11 22.1 1852.79 
Ƒ 11 22.1 2027.08 
Ƒ 11 22.1 2099.16 
Ƒ 12 22.7 1716.89 
Ƒ 12 22.7 1623.58 
Ƒ 12 22.7 1866.81 
Ƒ 12 22.7 2081.11 
Ƒ 12 22.7 2057.92 
Ƒ 13 24.1 1609.90 
Ƒ 13 24.1 1711.04 
Ƒ 13 24.1 1850.15 
Ƒ 13 24.1 1853.24 
Ƒ 13 24.1 2009.26 
Ƒ 13 24.1 2027.33 
Ƒ 13 24.1 1926.10 
Ƒ 14 25.1 2094.15 
Ƒ 15 25.9 1462.89 
Ƒ 15 25.9 2075.18 
Ƒ 16 27.0 1909.07 
Ƒ 17 28.0 1975.74 
Ƒ 18 29.4 1959.01 
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Table 2 
Sequence alignment of poneritoxins. Alignment of the seven poneritoxins sequenced in this study. 
Gaps were introduced to optimize the alignment. Identical residues are highlighted in grey and 
asterisks denote an amidated C-terminus. Percentage identity (% ID) is relative to U1-PONTX-Ae1a. 
Theoretical monoisotopic masses were calculated using GPMAW 10.0 software. 
 
Peptide1 Sequence % ID Mass [M] 
U1-PONTX-Ae1a ---WCASGCRKKRHGG-CSC* - 1732.73 Da 
U1-PONTX-Ae1b --RYCPSGCRKKPYGGGCSC* 70.6 1915.80 Da 
U1-PONTX-Ae1c -RSVCSNGCRPKPFGG-CSC* 62.5 1851.77 Da 
U1-PONTX-Ae1d -RSLCSNGCRPKPFGG-CSC* 62.5 1865.79 Da 
U1-PONTX-Ae1e -GVGCSSGCHK--VGGQCRCG* 52.9 1688.68 Da 
U1-PONTX-Ae1f SFYACTNGCWVKPGGG-CQC* 50.0 1974.76 Da 
U1-PONTX-Ae1g -GTGCSSGCHR--VGQQCRCG* 41.2 1789.70 Da 
 1Standard nomenclature system for naming ant-venom peptides [15].  
 
 
Table 3 
Statistics for the ensemble of U1-PONTX-Ae1a structures
1
. 
Experimental restraints
2
  
Interproton distance restraints-Total 190 
Intraresidue (|i–j| < 0)   50 
   Sequential (|i–j| =<1) 64 
   Medium range (1 < |i–j| < 5) 35 
   Long range (|i–j| >= 5) 41 
   Disulfide-bond restraints 6 
   Dihedral-angle restraints (φ, ψ) 27 
   Total number of restraints per residue 11.9 
R.m.s. deviation from mean coordinate structure (Å)  
   Backbone atoms (residues 2–16) 0.17 ± 0.04 
   All heavy atoms (residues 2–16) 0.93 ± 0.14 
Stereochemical quality
3
  
   Residues in most favored Ramachandran region (%) 93.6 ± 2.2 
Ramachandran outliers (%) 0 ± 0 
   Unfavorable side chain rotamers (%) 4.2 ± 4.3 
Clashscore, all atoms
4
  0 ± 0 
   Overall MolProbity score 1.3 ± 0.4 
1
All statistics are given as mean ± S.D. 
2
Only structurally relevant restraints, as defined by CYANA, are included. 
3
According to MolProbity (http://molprobity.biochem.duke.edu). 
4
Defined as the number of steric overlaps >0.4 Å per thousand atoms. 
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Table 4 
Sequences of small venom peptides reticulated by two disulfide bonds. Percentage identity 
(% ID) is relative to the first peptide (U1-PONTX-Ae1a). Cysteine residues are highlighted. 
Asterisk denotes C-terminal amidation. 
 
Peptide Specie Sequence % ID Target 
U1-PONTX-Ae1a Anochetus emarginatus WCASGCRKKRHGGCSC* - Cav channel 
Apamin Apis mellifera --CNCKAPETAL--CARRCQQH* 15 Kv channel 
Tertiapin Apis mellifera ALCNCNRIIIPHM-CWKKCGKK* 23.8 Kv channel 
MCDP Apis mellifera IKCNCKRHVIKPHICRKICGKN* 22.7 Kv channel 
Sarafotoxin 6b Atractaspis engaddensis CSCKDMTDKECLTFCHQDVIW 15 Endothelin receptor 
α-Conotoxin AuIB Conus aulicus ---GCCSYPPCFATNPD-C* 17.6 Nicotinic receptor 
α-Conotoxin EI Conus ermineus -RDOCCYHPTCNMSNPQIC* 17.6 Nicotinic receptor 
α-Conotoxin GI Conus geographus ---ECCNPA-CGRHYS--C* 18.8 Nicotinic receptor 
α-Conotoxin IMI Conus imperialis ---GCCSDP-CAWR----C* 17.6 Nicotinic receptor 
α-Conotoxin MII Conus magus ---GCCSNPVCHLEHSNLC* 17.6 Nicotinic receptor 
α-Conotoxin PnIB Conus pennaceus ---GCCSLPPCAANNPDYC* 17.6 Nicotinic receptor 
α-Conotoxin PIA Conus purpurascens -RDPCCSNPVCTVHNPQIC* 17.6 Nicotinic receptor 
α-Conotoxin SI Conus striatus ---ICCNPA-CGPKTS--C* 25.1 Nicotinic receptor 
ρ-Conotoxin TIA Conus tulipa FNWRCCLIPACRRNHKKFC* 23.5 Adrenergic receptor 
χ-Conotoxin MrIA Conus marmoreus -NGVCCGYKLCHO-----C 18.2 Noradrenalin receptor 
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Highlights 
 Anochetus emarginatus venom is mostly composed of disulfide-linked peptides. 
 U1-PONTX-Ae1a is a novel disulfide-linked peptide toxin with a unique 3D scaffold. 
 U1-PONTX-Ae1a has a β-hairpin motif with two antiparallel strands. 
 U1-PONTX-Ae1a reversibly paralyzes blowflies. 
 U1-PONTX-Ae1a inhibits human L-type voltage-gated calcium channels. 
